BioCentury
ARTICLE | Company News

Gland Pharma, Shanghai Fosun Pharmaceutical deal

August 15, 2016 7:00 AM UTC

Fosun will acquire an 86% stake in generics and injectables company Gland from investment firm KKR Floorline Investments Pte. Ltd. for up to $1.3 billion. The companies did not respond to inquiries. ...